Recombinant Pro-Omhep1, Recombinant Hepcidin

General Information


DRACP ID  DRACP03528

Peptide Name   Recombinant Pro-Omhep1, Recombinant Hepcidin

Sequence  MGSSHHHHHHSSGLVPRGSHMIPVNGVTELEEAASNDTPVAARHEMSMQSWMMPNHIREKRQSHLSMCSVCCNCCKNYKGCGFCCRF

Sequence Length  87

UniProt ID  G4VXJ6 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03528

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C404H629N133O121S15

Absent amino acids 

Common amino acids  SH

Mass  1130030

Pl  8.04

Basic residues  18

Acidic residues  6

Hydrophobic residues  17

Net charge  12

Boman Index  -17492

Hydrophobicity  -52.18

Aliphatic Index  43.68

Half Life 
  Mammalian: 0.8 hour
  Yeast: 10 min
  E.coli: >10 hour

Extinction Coefficient cystines  7490

Absorbance 280nm  87.09

Polar residues  33

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22051539

Title  Recombinant medaka (Oryzias melastigmus) pro-hepcidin: Multifunctional characterization

Doi Not available

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  6334

DRACP is developed by Dr.Zheng's team.